Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pebble Accelerator, also known as Tiger Jade Pebble Accelerator, is a boutique venture capital firm established to drive biomedical innovation and unique biotechnologies. Founded with the vision of transforming Hong Kong into a global biomedical hub, Pebble leverages its strategic location and investor relationships to support the growth of its portfolio companies. The firm operates from its office located at 1201, Hong Kong Li Ning Building, 318 Electric Road, North Point, Hong Kong.
Currently, Pebble Accelerator manages a portfolio of 13 companies, focusing on early-stage investments primarily in the biotech and healthcare sectors. The firm provides initial investments of approximately $200,000, aiming to facilitate connections between startups and global partners, particularly in China. This approach enhances the market reach and operational capabilities of its portfolio companies.
Notable milestones include the establishment of a consulting service that extends beyond its investment scope, acting as a bridge for startups seeking opportunities in Hong Kong and beyond. Pebble Accelerator's commitment to fostering biomedical innovation positions it as a key player in the global healthcare landscape.
Pebble Accelerator invests in early-stage startups, specifically in the biotech and healthcare sectors. The firm typically provides initial investments of around $200,000, targeting companies at the pre-seed, seed, and seed-plus stages. This investment strategy is designed to support startups in achieving their milestones while enhancing their growth potential.
In addition to funding, Pebble offers consulting services to companies outside its investment scope, acting as a connector to facilitate access to key markets and partners in Hong Kong and China. The firm seeks to establish Hong Kong as a global biomedical nexus by supporting startups that demonstrate innovative approaches to healthcare challenges. Pebble Accelerator values founders who are committed to their vision and possess a strong understanding of their market.
Pebble Accelerator's portfolio consists of 13 notable companies, each contributing to advancements in the biotech and healthcare sectors. The following companies are part of their current investment lineup:
This diverse portfolio highlights Pebble Accelerator's commitment to supporting innovative solutions in healthcare and biotechnology.
Isaac Lui: Isaac serves as the primary contact for Pebble Accelerator. He has a background in venture capital and is focused on supporting the growth of biomedical startups. His expertise lies in connecting startups with opportunities in Hong Kong and China.
To pitch Pebble Accelerator, founders should use the contact email provided: isaac.lui@tigerjadecapital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can enhance the chances of securing a meeting with the investment team.
Pebble Accelerator runs a single program known as the Pebble program. This program is designed to support early-stage biotech and healthcare startups by providing funding, mentorship, and strategic consulting services.
Eligibility for the Pebble program includes being an early-stage startup in the biotech or healthcare sectors. Interested startups can apply through the Pebble Accelerator website.
As of March 2023, Pebble Accelerator continues to actively support its portfolio companies and promote biomedical innovation in Hong Kong. The firm has been involved in facilitating connections between startups and global partners, enhancing their market reach and operational capabilities.
Recent updates on Pebble's website highlight ongoing efforts to connect startups with opportunities in China and beyond, reinforcing the firm's commitment to establishing Hong Kong as a global biomedical hub.
What are Pebble Accelerator's investment criteria?
Pebble Accelerator focuses on early-stage startups in the biotech and healthcare sectors, typically investing around $200,000. They look for companies that demonstrate innovative solutions and a strong understanding of their market.
How can startups apply or pitch to Pebble Accelerator?
Startups can pitch to Pebble Accelerator through their website at pebbleaccelerator.com. It is advisable to include a detailed business plan and information about the team and market potential in the pitch deck.
What makes Pebble Accelerator different from other investors?
Pebble Accelerator not only provides funding but also offers strategic consulting services to enhance the growth potential of its portfolio companies. They act as a connector to key markets and partners, particularly in Hong Kong and China.
What is Pebble Accelerator's geographic scope?
Pebble Accelerator operates globally, with a strong focus on Asia, particularly Hong Kong and China, to facilitate connections for its portfolio companies.
What is Pebble Accelerator's post-investment involvement like?
Pebble Accelerator actively supports its portfolio companies by providing consulting services and facilitating connections with global partners to help them achieve their milestones.
What is the typical check size for investments?
The typical check size for investments made by Pebble Accelerator is approximately $200,000.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.